Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Neuromuscular Blocking Agents of Short Duration

Abstract

FOR a number of years we have been interested in the neuromuscular blocking properties of bis-onium compounds derived from substituted tropane nuclei, in which linking of the quaternary nitrogens was effected by a polymethylene or aralkyl chain. We observed that such compounds produced a flaccid paralysis on injection into chicks but tended to be long acting. This observation led to the preparation of a series of similar compounds (Fig. 1) in which the linking chain contained two ester-groupings as in suxamethonium. The latter is known to produce short-acting block which is, however, of depolarizing character.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

HAINING, C., JOHNSTON, R. & SMITH, J. Neuromuscular Blocking Agents of Short Duration. Nature 183, 542–543 (1959). https://doi.org/10.1038/183542a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/183542a0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing